MDB Capital Holdings Appoints Experienced Financial Expert Jeb Terry Sr. to Board and Audit Committee
MDBH is trading near its 52-week low of $3.11 (2.9% above the low) on light trading volume (0.1× avg).
Summary
MDB Capital Holdings, LLC appointed Jeb Terry Sr., a seasoned investor and financial expert, as an independent director and audit committee member, while Susanne Meline resigned due to retirement.
Key Events · Executive and Board Changes · MDBH
-
Appointment of Independent Director
Jeb Terry Sr., a 73-year-old seasoned investor with over 20 years of experience in microcap medical and biotechnology, venture capital, and private equity, was appointed as an independent director, effective February 1, 2026.
-
Audit Committee Member & Financial Expert
Mr. Terry will serve as a member of the Board's audit committee and has been determined to be a 'financial expert' due to his extensive investment and business operational experience.
-
Director Compensation
Mr. Terry will receive an annual cash payment of $50,000 and an option award to acquire 100,000 Class A Shares, with vesting commencing on the first anniversary of the grant date.
-
Director Resignation
Susanne Meline resigned from the Board, effective February 1, 2026, citing general retirement after many years of service.
Analysis · MDBH · Finance
The appointment of Mr. Jeb Terry Sr. as an independent director and audit committee member is a positive development for MDB Capital Holdings. His extensive experience in microcap medical and biotechnology companies, venture capital, and as a financial expert, brings valuable strategic and governance oversight, particularly as the company's stock trades near its 52-week low. The compensation package, including options for 100,000 shares, reflects the company's valuation of his expertise. The simultaneous resignation of Ms. Susanne Meline is noted as a routine retirement.
At the time of this filing, MDBH was trading at $3.20 on NASDAQ in the Finance sector, with a market capitalization of approximately $32.4M. The 52-week trading range was $3.11 to $7.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.